Philippe Marchand - 31 Mar 2022 Form 4 Insider Report for BIOCEPT INC (BIOC)

Role
Chief Operations Officer
Signature
/s/ Philippe Marchand
Issuer symbol
BIOC
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 14:24:56 UTC
Previous filing
16 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 31 Mar 2022 Common Stock 150,000 $2.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on the first anniversary of March 7, 2022 with the balance vesting in equal monthly installments until fully vested on March 7, 2026.